This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Pen Injectors - Devices, Drugs, Combination Products

NEW YORK, March 19, 2013 /PRNewswire/ -- announces that a new market research report is available in its catalogue:

Pen Injectors - Devices, Drugs, Combination Products designs and the availability of an increasing number of drugs in pre-filled disposable cartridges and syringes are propelling the growth of injector pens at the expense of other drug delivery methods such as traditional syringes. Advances in synthetic materials and concurrent development partnerships between pen designers and drug developers are important factors in the growth of this segment. With product evaluations, industry data and forecasts, pen injector company profiles, and detailed analysis of design and economic factors, this report has been organized and written to provide pharmaceutical professionals, drug delivery market participants, and healthcare organizations with all of the information necessary to understand the growing importance of pen injectors on drug development and delivery.

Highlights• Provides detailed analysis of pen injector market segments, market dynamics and market demographics• Analyzes therapeutic demand drivers and evaluates commercial pen injector products in eleven major therapeutic segments• Analyzes design factors, material selection issues, technologies and market development issues• Charts product data, market share, and forecasts to 2018• Profiles injectable drug and device participants, their pen injector product development activities, business strategies, and corporate alliances and affiliations

Summary of Contents Executive Summary Injectable Drug Sector Market DynamicsThe Injectable Drug EcosystemDrug Classes, Indications and DemandWhat's Driving the Growth in Pen InjectorsBiological Drugs ProliferatingGrowth of Self-AdministrationShifting Demographics Device Design InnovationCompetitive LandscapeRisk Factors

Pen Injector Design Selection FactorsStandardized Pen PlatformsCustom Pen DesignsReusable PensPrefilled Pen CartridgesDisposable PensDual Chamber PensVariable vs Fixed Dosing AutoinjectorsReusable AutoinjectorsDisposable Autoinjectors

Important Pen-Delivered Drug ClassesAnticholonergicsDopamine ReceptorsHematopoieticsHuman Growth HormoneImmune ModulatorsInsulins and AntihyperglycemicsParathyroid HormoneReproductive HormonesSerotonin AntagonistsSympathomimetics

Pen Injectors - Therapeutic Sector Assessment AnemiaInflammatory Autoimmune DiseasesDiabetesEmergency MedicineHepatitisHormone ReplacementMultiple SclerosisOsteoporosisReproductive HealthOther Commercial Pen Markets & Products

Market FactorsRegulatory ConsiderationsPatient Preferences and ComplianceManaged Care InitiativesPrivate Labeling

Pen Injectors - Company Profiles

To order this report: Drug_Delivery_Technology Industry: Pen Injectors - Devices, Drugs, Combination Products

__________________________Contact Clare: clare@reportlinker.comUS:(339) 368 6001Intl:+1 339 368 6001


1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.74 0.00%
FB $117.58 0.00%
GOOG $693.01 0.00%
TSLA $240.76 0.00%
YHOO $36.60 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs